Investments & digital assets › F8949.D.X175
F8949.D.X175 · federal · F8949 line D.X175
Delmar Pharma (acquired 2023-03-10, sold 2025-07-22; proceeds 1,769.43, basis 1,589.39)
180.04
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_desc · “Lot X175 description”
read as “Delmar Pharma” → Delmar Pharma
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_acq · “Lot X175 date acquired”
read as “03/10/2023” → 2023-03-10
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_sold · “Lot X175 date sold”
read as “07/22/2025” → 2025-07-22
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_proceeds · “Lot X175 proceeds”
read as “1,769.43” → 1,769.43
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_basis · “Lot X175 cost basis”
read as “1,589.39” → 1,589.39
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 16 · field X175_wash · “Lot X175 wash sale loss disallowed”
read as “0.00” → 0
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: 180.04v2 · 2026-03-19: 180.04v3 · 2026-06-23: 180.04
Adjust this number
Evidence & discussion
Record how you verified it